Sign in to confirm you’re not a bot
This helps protect our community. Learn more

Immuron on How their Gastrointestinal and Digestive Health Immune Supplements Work + FY23 Sales

Planet MicroCap
12.9K subscribers
<__slot-el>
<__slot-el>
149 views 1 year ago
Planet MicroCap spoke with Steven Lydeamore, CEO of Immuron Ltd. (ASX: IMC) (NASDAQ: IMRN) via Zoom to discuss (Click the time stamp to jump to each answer, or watch it all): [0:28] Quick overview and history of Immuron Ltd. [2:47] What makes the company's products unique and different compared to their peers [4:17] Biological reaction [6:01] FY23 sales (unaudited net sales) results of its over-the-counter gastrointestinal and digestive health immune supplement Travelan® and Protectyn®: https://finance.yahoo.com/news/immuro... [7:43] Value catalysts for the rest of 2023, going into 2024 traveler's diaherea For more information about Immuron Limited, please visit: https://www.immuron.com.au/ The interview may contain forward looking statements about Immuron Limited. See Immuron Limited's periodic filings with the Securities and Exchange Commission and the Australian Securities Exchange for more complete information. About Immuron Immuron …...more
...more
Immuron on How their Gastrointestinal and Digestive Health Immune Supplements Work + FY23 Sales
N/ALikes
149Views
2023Jul 19
Planet MicroCap spoke with Steven Lydeamore, CEO of Immuron Ltd. (ASX: IMC) (NASDAQ: IMRN) via Zoom to discuss (Click the time stamp to jump to each answer, or watch it all): [0:28] Quick overview and history of Immuron Ltd. [2:47] What makes the company's products unique and different compared to their peers [4:17] Biological reaction [6:01] FY23 sales (unaudited net sales) results of its over-the-counter gastrointestinal and digestive health immune supplement Travelan® and Protectyn®: https://finance.yahoo.com/news/immuro... [7:43] Value catalysts for the rest of 2023, going into 2024 traveler's diaherea For more information about Immuron Limited, please visit: https://www.immuron.com.au/ The interview may contain forward looking statements about Immuron Limited. See Immuron Limited's periodic filings with the Securities and Exchange Commission and the Australian Securities Exchange for more complete information. About Immuron Immuron Limited (ASX: IMC, NASDAQ: IMRN), is an Australian biopharmaceutical company focused on developing and commercializing orally delivered targeted polyclonal antibodies for the treatment of inflammatory mediated and infectious diseases. For more information visit: http://www.immuron.com Subscribe NOW to Planet MicroCap: http://bit.ly/1Q5Yfym Get more Planet MicroCap: Website: https://planetmicrocap.com/ Follow Planet MicroCap:   / planetmicrocap   Like Planet MicroCap:   / planetmicrocap   Follow Planet MicroCap on LinkedIn:   / plan.  . Planet MicroCap is the Official YouTube Channel for the MicroCap markets by providing news, insights, education tools and expert commentary. Subscribe now to be notified when new CEO video interviews, WALL STREET VIEWS with investing experts and new episodes of the Planet MicroCap Podcast are LIVE!

Follow along using the transcript.

Planet MicroCap

12.9K subscribers